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Background: A standard short-term inhalation study (STIS) was applied for hazard assessment of 13 metal oxide
nanomaterials and micron-scale zinc oxide.
Methods: Rats were exposed to test material aerosols (ranging from 0.5 to 50 mg/m3) for five consecutive days
with 14- or 21-day post-exposure observation. Bronchoalveolar lavage fluid (BALF) and histopathological sections of
the entire respiratory tract were examined. Pulmonary deposition and clearance and test material translocation into
extra-pulmonary organs were assessed.
Results: Inhaled nanomaterials were found in the lung, in alveolar macrophages, and in the draining lymph nodes.
Polyacrylate-coated silica was also found in the spleen, and both zinc oxides elicited olfactory epithelium necrosis.
None of the other nanomaterials was recorded in extra-pulmonary organs. Eight nanomaterials did not elicit
pulmonary effects, and their no observed adverse effect concentrations (NOAECs) were at least 10 mg/m3. Five
materials (coated nano-TiO2, both ZnO, both CeO2) evoked concentration-dependent transient pulmonary
inflammation. Most effects were at least partially reversible during the post-exposure period.
Based on the NOAECs that were derived from quantitative parameters, with BALF polymorphonuclear (PMN)
neutrophil counts and total protein concentration being most sensitive, or from the severity of histopathological
findings, the materials were ranked by increasing toxic potency into 3 grades: lower toxic potency: BaSO4; SiO2.
acrylate (by local NOAEC); SiO2.PEG; SiO2.phosphate; SiO2.amino; nano-ZrO2; ZrO2.TODA; ZrO2.acrylate; medium toxic
potency: SiO2.naked; higher toxic potency: coated nano-TiO2; nano-CeO2; Al-doped nano-CeO2; micron-scale ZnO;
coated nano-ZnO (and SiO2.acrylate by systemic no observed effect concentration (NOEC)).
Conclusion: The STIS revealed the type of effects of 13 nanomaterials, and micron-scale ZnO, information on their
toxic potency, and the location and reversibility of effects. Assessment of lung burden and material translocation
provided preliminary biokinetic information. Based upon the study results, the STIS protocol was re-assessed and
preliminary suggestions regarding the grouping of nanomaterials for safety assessment were spelled out.
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Nanomaterials offer unique mechanical, chemical, elec-
trical or optical properties that are being exploited for a
broad spectrum of applications, including a variety of in-
dustrial and consumer products and products and de-
vices in the medical field. However, the increased use of
nanomaterials has also raised concerns about undesir-
able human health effects, especially upon inhalation
uptake. Information on possible toxic effects of nanoma-
terials is essential to ensure occupational and consumer
safety. Standard toxicological testing methods, such as
the 90-day rodent inhalation study, have been recog-
nized as generally being applicable in meeting this
request. However, such studies are considerably time-
consuming and cost-intensive and not suitable for
screening purposes or for the testing of larger numbers
of compounds.
In addressing these drawbacks of long-term studies, a
rat short-term inhalation study protocol (STIS) was de-
veloped within the project NanoCare (http://www.ptj.de/
nanocare; of note: all websites were accessed in March
2014) supported by the German Federal Ministry of
Education and Research and the European Sixth Frame-
work Programme project NanoSafe2 (www.nanosafe.
org). The STIS protocol takes into account the specific
properties of nanomaterials and encompasses a 5-day in-
halation exposure period with a subsequent 3-week
post-exposure period. During a first validation of this
protocol, nano-TiO2 was applied as a model substance
[1], and its effects were compared to micron-scale TiO2
and micron-scale quartz. The results of this initial study
with TiO2 stood in good agreement with those obtained
in a subchronic 90-day study [2].
The study at hand presents STIS data for nanomaterials,
which were tested either during product development, i.e.
TiO2 (T-lite SF™) and ZnO (NM-111), or in the context of
research projects, i.e. nano-CeO2, Al-doped nano-CeO2,
ZrO2 (with or without surface modifications), naked
amorphous silica and four types of surface-coated silica,
and BaSO4 (NM-220). Of note, NM-x numberings refer to
the respective numberings of OECD reference nano-
materials, as they have been coded in the list of the
OECD WPMN Sponsorship Program for the Testing
of Manufactured Nanomaterials (http://www.oecd.org/
science/nanosafety/ and http://ihcp.jrc.ec.europa.eu/our_
activities/nanotechnology/nanomaterials-repository).
The STIS for both CeO2 nanomaterials and the ZrO2
without surface modification were performed in the
context of the above-mentioned NanoCare project, and
the STIS for the surface-functionalized ZrO2, all SiO2
materials and BaSo4 were conducted as a part of the
‘nanoGEM’ project (Nanostrukturierte Materialien –
Gesundheit, Exposition und Materialeigenschaften –
‘Nanostructured Materials – Health, Exposure and MaterialCharacteristics’; www.nanogem.de) funded by the German
Federal Ministry of Education and Research. For a few of
the test materials of the present study, data from chronic
and subchronic studies are already available, and a com-
parison of the results from short-term versus long-term
studies has recently been published [3], revealing consistent
results regardless of the differing exposure periods.
Coated nano-TiO2 is being used as a sunscreen in cos-
metic products. Nanosized TiO2 has been observed to
elicit inflammatory effects [4-6] and morphological
changes in the lung [2,7].
Just as TiO2, ZnO nanomaterials are used as UV ab-
sorbers. In workers, ‘metal fume fever’ effects caused by
ZnO have been observed to be potent, but transient;
in vitro, ZnO nanomaterials have been recorded to be
highly toxic to many types of cells with concordant ef-
fects observed in vivo upon instillation, to the lung tis-
sue [8]. Already at a bolus concentration of 0.3 mg
instilled into the rat lung, ZnO nanoparticles induced
collagen formation 4 weeks post-instillation [9]. This
lung burden can be achieved by 4-week inhalation ex-
posure to 2 mg/m3 (6 h/day, 5 days/week), assuming
10% deposition and the clearance rate of a poorly soluble
particle. ZnO particles selected for the present study
were a coated nano-ZnO (OECD NM-111) and a
micron-scale, uncoated ZnO.
Synthetic naked amorphous silica can be subdivided
into wet process-manufactured (precipitated) silica and
pyrogenic silica. The surface of silica particles can add-
itionally be coated with a variety of organic materials
(overview in [10]). Synthetic amorphous silica particles
are being used as filling materials in plastics, lacquers,
paints and tyres but also in pharmaceuticals, cosmetics,
and foods. In contrast to crystalline silica, the biological
effects of synthetic naked amorphous silicas appear to
be transient and, depending on the concentration, re-
versible [10-12]. Precipitated uncoated amorphous silica
(in the following: SiO2.naked) and four surface modifica-
tions thereof (SiO2.polyacrylate, SiO2.polyethyleneglycol
(SiO2.PEG), SiO2.phosphate, SiO2.amino) were tested in
the present study.
Nanosized BaSO4 is being used as a filling material in
polymer compositions to increase scratch resistance while
conserving transparency. Upon inhalation, micron-scale
BaSO4 only induces very slight transient inflammatory re-
actions [13], and it has been used for a long time as a
radio-contrast agent for medical diagnostic purposes. By
contrast, nanosized BaSO4 particles have a much larger
surface area and have not yet been tested via the inhal-
ation route.
Industrial areas of use of ZrO2 particles include appli-
cations in foundry sands, refractories, and ceramics. The
material is also used for the coating of hip joint endo-
prostheses or dental prostheses. ZrO2 particles increase
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nishes. Micron-scale ZrO2, as investigated by Pott and
Roller [14], possesses a comparatively low carcinogenic
potential under severe overload conditions achieved by
intratracheal instillation of bolus doses of 60 mg/rat
lung. So far, there are no data available on the pulmon-
ary effects of nano-ZrO2 particles either without or with
surface modification. Hence the nano-ZrO2 and surface-
modified nano-ZrO2 (ZrO2.trioxadecanoic acid (ZrO2.
TODA) and ZrO2.polyacrylate) evaluated in the present
study provide a first insight on their pulmonary effects.
Nanoparticular CeO2 is widely used e.g. in solar cells,
as additive in diesel and automotive catalytic converters,
as UV absorbent, for glass or ceramic applications and
as polishing agent for silicon-wafers. The oxidative and
lung toxicity potential of nano-CeO2 has recently been
demonstrated in a first acute inhalation study [15] in
which 641 mg/m3 were applied to rats for 4 h in accord-
ance with OECD test guideline (TG) 403. Under these
experimental conditions, acute signs of inflammation
and oxidative damage including reduced tissue glutathi-
one and increased levels of malondialdehyde were ob-
served. All of these effects were partially reversible
within 14 days, whereas the CeO2 particles persisted in-
side the alveoli and lung tissue for a longer period. The
results from this first inhalation study were consistent
with previous instillation studies [16,17] and with earlier
reports on the occurrence of pneumoconiosis in workers
exposed to (micron-scale) CeO2 particles [18,19]. Two
types of CeO2 nanomaterials were tested in the present
study, which partly differed in chemical composition,
with the one being pure and the other being doped with
a low percentage of aluminium.
As a rule, the tested aerosol concentration ranges en-
compass the nuisance dust limit laid down by the
German Federal Ministry of Labour and Social Affairs, i.e.
1.25 mg/m3 for granular respirable dusts that can reach
the alveoli [20,21]. The highest concentrations were se-
lected to challenge the lung clearance mechanism under
conditions of beginning lung overload, which was usually
at 10 mg/m3. For coated nano-TiO2 (T-Lite SF™), this
concentration had caused adverse effects in previously
performed subchronic studies. Lower or higher concen-
trations were selected, as appropriate, based on existing
data from previous toxicological tests, e.g. 50 mg/m3 for
BaSO4. Aerosols were characterized with respect to size
distribution and number concentration using ISO-
standardized methods or, alternatively, characterization
methods recommended by the OECD.
The biological effects of the nanomaterials in rats were
determined by analysing the bronchoalveolar lavage fluid
(BALF) and blood samples as well as by performing
histopathological examinations of all respiratory tract
tissues. For all test substances, the organ burden, i.e. thecontent of test material, was determined in the lung and
lung-associated mediastinal lymph nodes, and for most
test substances, also in extra-pulmonary organs. Add-
itional information, i.e. cell proliferation rates, an early
indicator for epithelial hypertrophy, and apoptotic reac-
tions in the terminal bronchi and alveoli, cytokine profiles
in the blood, BALF and/or lung tissue homogenates, or
transmission electron microscopic (TEM) evaluation of
organs, were additionally collected for selected substances.
In assessing whether effects were to be considered
treatment-related or incidental, they were not only com-
pared to the corresponding effects occurring in the control
groups, but also to historical control data (c.f. Supplemen-
tary Information (SI), Additional file 1: Table S1, for histor-
ical control ranges of BALF and lung tissue homogenate
parameters of male Crl:Wi(Han) rats, 8–12 weeks of age).
Results
Characterization of the test materials
A comprehensive overview of the physico-chemical
characteristics of the test materials is provided in Table 1.
Details of this characterization have previously been
published for those test materials that were delivered as
powders (i.e. TiO2, both ZnO, both CeO2, BaSO4, nano-
ZrO2) [22] and for those materials that were delivered as
suspensions (i.e. all SiO2; ZrO2.TODA; ZrO2.acrylate)
[23]. Morphological images of all test substances, except
for SiO2.acrylate, obtained by scanning electron micros-
copy (SEM) and TEM, are presented in Figures 1 and 2.
Characterization of the test aerosols
The achieved aerosol concentrations were generally
close to the corresponding target concentrations
(Table 2). Evaluation of the particle size distribution con-
firmed that the aerosols were respirable for rats. Size
measurements in the submicrometer range conducted
with the Scanning Mobility Particle Sizer (SMPS) re-
vealed that the aerosols consisted of few primary parti-
cles in the range of 14 to 90 nm and of agglomerates
with diameters up to 3 micrometres, with the majority
of the agglomerates (typically 80%) being in the sub-
micrometre range.
Toxicological effects
An overview of the toxicological effects elicited by the
13 nanomaterials and micron-scale ZnO is provided in
Table 3, with details on affected BALF parameters pre-
sented in Figures 3A-3F and the Supplementary Infor-
mation (SI) Additional file 1: Tables S1-S9. The
incidences and severities of the histological findings in-
duced by the TiO2, ZnO, and CeO2 test materials are
summarized in SI, Additional file 2: Tables S10-S15. The
following sub-sections present the toxicological effects
observed for each test material, and the subsequent
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aCatalytic events per photon impinging on the surface, as specified in DIN 52980.
bSurface reactivity and ROS formation were determined relative to the ‘reference material’ deuterium oxide (D2O;
2H2O). Assuming a 30% variability of the methodology, only measurements >1.3 are considered
relevant. Of note, this value should only serve as a guiding principle, and not as an absolute value.
Abbreviations: AAN average agglomeration number; derived from the ratio of the volume-based median particle size to the average equivalent spherical volume derived from the BET gas adsorption, AUC analytical
ultracentrifugation, BET method of Brunauer-Emmett-Teller, D50 medium value of the particle size distribution, DMEM/FCS Dulbecco’s Modified Eagle Medium supplemented with 10% fetal calf serum, ESR + CPH Electron
spin resonance making use of centrophenoxine spin traps, ESR + DMPO Electron spin resonance making use of dimethyl-pyrroline-N-oxide spin traps, n.a. not applicable, n.d. not determined, n.m. not measurable, p-f s
particle-free supernatant, PPS primary particle size, ROS reactive oxygen species, SEM scanning electron microscopy, SIMS secondary ion mass spectrometry, TEM transmission electron microscopy, XPS x-ray photoelec-
















Figure 1 Scanning and transmission electron microscopy (SEM and TEM) images of the powder test materials. A: micron-scale ZnO, B:
BaSO4, C: nano-ZrO2, D: coated nano-TiO2, E: coated nano-ZnO, F: nano-CeO2, G: Al-doped nano-CeO2. A-C: SEM images. D-G: TEM images. Note
slightly different sets of scales in order to point to the individual characteristics of the respective test materials.
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organ burden analysis (Table 4). An overview of the
study design, indicating which specific examinations
were conducted in the animal groups treated with either
of the test materials, is provided in Table 5.Figure 2 Scanning electron microscopy images of the suspension tes
phosphate, E: ZrO2.TODA, F: ZrO2.acrylate. Note slightly different sets of sca
test materials.Coated nano-TiO2 (T-Lite SF™)
Inhalation exposure to 10 mg/m3 coated nano-TiO2
caused markedly increased polymorphonuclear (PMN)
neutrophil and monocyte counts in the BALF differen-
tial cell counts, accompanied by increased total cellt materials. A: SiO2.naked, B: SiO2.PEG, C: SiO2.amino, D: SiO2.
les in order to point to the individual characteristics of the respective


















Measurement 1 Measurement 2
Coated nano-TiO2
0.5 0.6 ± 0.1 0.8/3.4 0.7/4.4 33905 0.131
2 2.0 ± 0.1 0.4/3.1 0.2/4.0 114889 0.153
10 10.7 ± 1.2 0.4/3.0 0.4/3.6 205660 0.167
Micron-scale ZnO 12.5 15.3 ± 1.6 1.0/2.2 1.1/2.3 219031 0.167
Coated nano-ZnO (NM-111)
0.5 0.6 ± 0.2 0.9/2.4 1.3/2.4 22126 0.144
2.5 2.8 ± 0.6 0.8/2.5 0.8/2.8 87044 0.177
12.5 13.8 ± 2.0 0.8/2.4 0.9/2.4 159381 0.198
SiO2.naked
0.5 0.5 ± 0.1 1.3/3.0 1.7/3.4 20167 0.106
2.5 2.4 ± 0.1 1.0/2.3 1.2/2.2 47866 0.101
10 10.4 ± 1.3 1.3/2.2 1.5/2.3 130972 0.127
50 52.6 ± 4.3 2.0/2.8 2.2/2.6 172204 0.114
SiO2.acrylate
0.5 0.6 ± 0.1 1.1/ 2.4 1.2/2.3 13607 0.090
2.0 2.1 ± 0.2 1.0/2.3 1.0/2.3 30623 0.100
10 9.7 ± 0.4 1.1/2.8 1.1/2.3 159381 0.110
SiO2.PEG
2 2.05 ± 0.12 1.0/2.8 1.0/2.5 17080 0.093
10 10.0 ± 1.4 1.0/2.7 1.1/2.7 73384 0.100
50 54.1 ± 1.0 1.3/2.8 1.3/2.8 164639 0.125
SiO2.phosphate
2 2.9 ± 0.6 0.8/3.6 0.9/2.6 109566 0.09
10 10.0 ± 1.2 1.4/2.6 1.3/2.3 105863 0.09
50 51.5 ± 5.4 1.4/2.5 1.6/2.4 308408 0.10
SiO2.amino
2 2.1 ± 0.4 0.8 /2.4 0.9/4.0 11036 0.09
10 10.2 ± 1.4 1.8/2.0 1.4/2.2 146680 0.10
50 50.4 ± 3.7 1.7/2.7 1.3/2.8 282401 0.10
Nano-BaSO4 (NM-220)
2 2.5 ± 0.3 1.3/2.4 1.2/2.2 71945 0.173
10 13.1 ± 0.7 1.5/2.1 1.4/2.3 245438 0.198
50 53.4 ± 9.7 1.1/2.2 0.9/2.3 258642 0.188
Nano-ZrO2
0.5 0.5 ± 0.1 1.6/2.1 1.3/2.0 8580 0.091
2.5 2.6 ± 0.3 1.3/2.0 1.4/2.3 16024 0.138
10 9.6 ± 1.2 1.8/2.2 2.0/1.8 76924 0.149
ZrO2.TODA
2 2.0 ± 0.1 1.3/4.0 1.2/3.9 59496 0.08
10 10.6 ± 0.3 1.0/4.7 1.1/4.2 72398 0.11
50 52.2 ± 1.1 1.5/3.3 1.2/4.3 124267 0.13
ZrO2.acrylate
2 1.9 ± 0.1 0.6 /2.9 0.7/2.7 54218 0.06
10 10.1 ± 1.0 1.0/2.6 0.8/2.8 133269 0.06
50 50.5 ± 4.7 1.4/2.7 1.3/3.4 166557 0.06
Nano-CeO2
0.5 0.8 ± 0.3 0.6/2.4 0.7/2.9 47745 0.111
2.5 3.0 ± 0.2 0.9/2.3 0.8/2.3 126354 0.144
10 11.6 ± 0.5 0.8/2.5 0.7/2.4 458415 0.172
Al-doped nano-CeO2
0.5 0.6 ± 0.3 1.3/2.1 1.1/2.3 39695 0.252
2 2.1 ± 0.5 2.2/1.9 1.8/1.9 - -
10 9.2 ± 2.6 2.4/2.1 1.8/1.9 82383 0.200
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0.5, 2.0, 10.0 0.5 Increased total cell counts, and
PMN neutrophils, monocytes,
total protein, GGT, LDH, ALP and
NAG (cytokines not measured)
Lung: pigment-loaded alveolar





Micron-scale ZnO 12.5 n.a. Increased total cell counts and
PMN neutrophils, lymphocytes,
monocytes, total protein, GGT,
LDH, ALP and NAG. Many
mediators increased; above 10-
fold as compared to respective
control values: clusterin; CRP;
MCP-1; MCP-3; MDC; MPO; OPN.
(Monocyte data not shown in
Additional file 1: Table S1)
Nasal cavity: severe multifocal
necrosis of olfactory epithelia
Lung: Increased absolute (+27%)














0.5, 2.5, 12.5 0.5 Increased total cell counts and
PMN neutrophils, lymphocyte,
monocyte, total protein, GGT,
LDH, ALP and NAG. Many
mediators increased; above 10-
fold at highest concentration as
compared to respective control
values: CINC-1; clusterin; cystatin
C; GCP-2; MCP-1; M-CSF; MDC;
MPO; OPN
Nasal cavity: moderate












SiO2.naked 0.5; 2.5; 10.0;
50.0
2.5 Slightly increased PMN
neutrophils and lymphocytes
Slightly increased neutrophil
counts in blood after the end of
exposure (data not shown)
Respiratory tract: Multifocal
macrophage aggregates;
Exacerbation towards a slight
multifocal inflammation after






SiO2.acrylate 0.5; 2.0; 10.0 local effects: ≥ 10;
systemic effects: 0.5
No adverse findings Respiratory tract: no adverse
effects, Spleen: increased weight
(+ 25%) without histological
correlate; particles and high
numbers of thrombocytes in the





SiO2.PEG 2.0; 10.0; 50.0 ≥ 50 No adverse findings No adverse findings n.a.
SiO2.phosphate 2.0; 10.0; 50.0 ≥ 50 No adverse findings No adverse findings n.a.
SiO2.amino 2.0; 10.0; 50.0 ≥ 50 No adverse findings No adverse findings n.a.
Nano-BaSO4
(NM-220)
2.0; 10.0; 50.0 ≥ 50 No adverse findings No adverse findings n.a.
Nano-ZrO2 0.5, 2.5, 10.0 ≥ 10 No adverse findings No adverse findings n.a.
ZrO2.TODA 2.0; 10.0; 50.0 ≥ 50 No adverse findings No adverse findings n.a.
ZrO2.acrylate 2.0; 10.0; 50.0 ≥ 50 No adverse findings No adverse findings n.a.
Nano-CeO2 0.5, 2.5, 10.0 < 0.5 Changes of all cytological and
biochemical parameters in BALF;
increased levels of Changes of
CINC-1, IFNγ, IL-1α, MCP-1, M-
CSF, in BALF and lung tissue










0.5, 2.0 10.0 < 0.5 Changes of all cytological and
biochemical parameters in BALF,
increased MCP-1 and CINC-1 in
BALF, increased IL1-α in lung
tissue
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Figure 3 Comparison of changes in BALF. A: coated nano-TiO2. B: micron-scale ZnO; C: coated nano-ZnO; D: SiO2.naked; E: nano-CeO2;
F: Al-doped nano-CeO2. Changes are shown as x-fold differences compared to the corresponding control values using a logarithmic scaling.
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final exposure (i.e. in the exposure groups). Of note, cy-
tokines and chemokines were not assessed for the coated
nano-TiO2 test groups. Slight increases of a number of
BALF parameters were also recorded for the rats of the
mid test substance concentration group exposed to
2 mg/m3 coated nano-TiO2 (Table 3; Figure 3A; and
Additional file 1: Table S1, Additional file 1: Table S2).
Slightly increased BALF parameters were still observed
three weeks post-exposure (i.e. in the recovery groups).
Histological examination of the lungs of the high
concentration test group (10 mg/m3) revealed numerous
pigment-loaded alveolar macrophages within the alveoli
and slight diffuse histiocytosis, whereas the pulmonary
epithelium appeared unchanged. No treatment-related ef-
fects were found in the upper airways (i.e. nasal cavity, lar-
ynx level, trachea, and carina) or in the mediastinal lymph
nodes (Table 3; and Additional file 1: Table S1, Additional
file 2: Table S10). Overall, coated nano-TiO2 caused mild
pulmonary inflammation that was not fully reversible,
with a NOAEC of 0.5 mg/m3. This finding is consistent
with previous STIS data evaluating TiO2 P25 [1].Micron-scale ZnO and coated nano-ZnO (NM-111)
No clinical signs of toxicity, but markedly decreased
body weight gain, were observed in the animal groups
exposed to 2.5 and 12.5 mg/m3 coated nano-ZnO or
12.5 mg/m3 micron-scale ZnO 24 h after the final expos-
ure. This effect was assessed as being a result of the sys-
temic toxicity of released Zn2+ ions. Body weight gain
returned to the control value at the end of the post-
exposure period (data not shown).Hematology parameters, acute phase protein and cyto-
kine levels in the blood were not affected in any of the
ZnO-treated rats. Increased absolute and relative lung
weights (by approx. 30%) were observed in animals ex-
posed to micron-scale ZnO (data not shown).
Inhalation exposure to both coated nano-ZnO and
micron-scale ZnO caused pulmonary inflammation,
which was characterized by considerably increased
PMN neutrophil and lymphocyte counts in the differ-
ential cell counts, and increased total cell counts in the
BALF, which were dose-dependent for coated nano-
ZnO (Table 3; Figure 3B; and Additional file 1: Table
S1, Additional file 1: Table S3) and accompanied by
elevated BALF enzyme activities, total protein, and
chemokine and cytokine concentrations. Regarding the
latter, the levels of 25 and 26, respectively, of a total of
68 examined cell mediators examined (Additional file
1: Table S3) were significantly increased after the final
exposure to 12.5 mg/m3 coated nano-ZnO or micron-
scale ZnO. For coated nano-ZnO, most parameters
were also increased at 2.5 mg/m3. Even at the lowest
aerosol concentration of 0.5 mg/m3 coated nano-ZnO,
the BALF enzyme glutamyltransferase (GGT), and the
inflammatory mediators cytokine-induced neutrophil
chemoattractant-1 (CINC-1; the rat homologue to
interleukin (IL)-8), clusterin, and tissue inhibitor of
metalloproteinases-1 (TIMP-1) were increased. Almost
all BALF parameters returned to the respective levels
of the control group after the 3-week post-exposure
period. Overall, the pattern of changes was similar for
both types of ZnO, with stronger effects elicited by
coated nano-ZnO (Table 3; and Additional file 1: Table
S1, Additional file 1: Table S3).
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exposed to either micron-scale or coated nano-ZnO
revealed pronounced PMN neutrophil, macrophage and
lymphocyte infiltration (in accordance with the findings
in the BALF), and a moderate multifocal rise in the
number of alveolar macrophages, accompanied by an
activation of the mediastinal lymph nodes. Most effects
were fully reversible within the post-exposure period,
after which only slight or moderate histiocytosis per-
sisted in all animals. Overall, the histopathological
effects caused by both substances were very similar, but
compared to micron-scale ZnO, coated nano-ZnO-
mediated effects were less severe or had a lower incidence
(Table 3; and Additional file 1: Table S1, Additional
file 2: Table S11).
In the upper respiratory tract, i.e. the nasal cavity,
of all rats exposed to the ZnO materials multifocal
necrosis of the olfactory epithelium was recorded that
was moderate upon exposure to coated nano-ZnO and
severe upon exposure to micron-scale ZnO. In test
groups treated with 12.5 mg/m3 micron-scale ZnO or
coated nano-ZnO, slight irregularities of the olfactory
epithelium remained visible after the three-week expos-
ure-free period (Table 3; and Additional file 1: Table S1,
Additional file 2: Table S12).
In the animals exposed to coated nano-ZnO or micron-
scale ZnO increased cell proliferation in the terminal
bronchioli were observed, which were concentration-
dependent for coated nano-ZnO. Micron-scale ZnO also
caused increased cell proliferation rates in the large bron-
chi and in the alveoli. In general, a higher proliferation
rate was recorded after exposure to 12.5 mg/m3 micron-
scale ZnO than to the same concentration of coated
nano-ZnO (Table 3; and Additional file 1: Table S1,
Additional file 2: Table S13). Apoptosis was only ob-
served in the test substance groups treated with
12.5 mg/m3 of micron-scale ZnO or coated nano-ZnO
(data not shown).
Taking into account the changes in the BALF and the
morphological findings in the lungs, mediastinal lymph
nodes and nasal cavities, the NOAEC for coated nano-
ZnO was assessed as being 0.5 mg/m3. For micron-scale
ZnO, no NOAEC was set since it was only tested at one
(high) concentration. Based upon the observed results,
its NOAEC is likely to be in the same range as the one
assessed for coated nano-ZnO, since both materials in-
duced similar effects. While alterations of BALF parame-
ters were more pronounced for coated nano-ZnO than
for micron-scale ZnO, coated nano-ZnO elicited less
pronounced adverse effects in the upper airways and
only minor effects in regard to cell proliferation. These
differences can most likely be explained by a reduced
dissolution rate due to the coating of the nanoparticles.
Similarly, coated nanosized ZnO NM-111 was slightlyless toxic in rat precision-cut lung slices than uncoated
nanosized ZnO (NM-110) [24].
Amorphous silica-based materials
Non-coated amorphous silica (SiO2.naked) Inhalation
exposure to an aerosol concentration of 50 mg/m3 naked
amorphous silica caused marginal systemic inflamma-
tion, evidenced by slight and transient increases in gran-
ulocyte counts in the blood (data not shown). Increased
PMN neutrophil and lymphocyte counts were present in
the BALF of this high concentration test group shortly
after exposure and (in the 10 and 50 mg/m3 test groups)
3 weeks post-exposure. Histologically, multifocal macro-
phage aggregates were observed in the lung shortly after
exposure. This finding exacerbated towards a slight multi-
focal pulmonary inflammation by the end of the 3-week
exposure free period (Table 3).
At concentrations up to 50 mg/m3, SiO2.naked did not
induce any significant changes of BALF cytokines or
chemokines in the exposure groups, i.e. those rats that
were euthanized shortly after the final exposure, or in
the recovery groups that were euthanized after the 3-
week post-exposure period (Additional file 1: Table S12).
The NOAEC of SiO2.naked was assessed as being
2.5 mg/m3.
By comparison, Arts et al. [12] submitted three different
synthetic amorphous silicas and quartz to a STIS with 3-
month post-exposure period. For all three amorphous sil-
ica, effects were observed at concentrations that were sig-
nificantly lower than those from previously published
studies investigating comparable substances or from the
STIS performed within the present study: While only mild
effects were observed in the BALF after exposure to 10 or
50 mg/m3 naked amorphous silica in the present study,
marked effects were already detected after exposure to
25 mg/m3 of all three silicas investigated by Arts and co-
workers [12]. These differences in toxicity can most likely
be explained by differences in material properties.
Polyacrylate-coated amorphous silica (SiO2.acrylate)
Inhalation exposure to aerosol concentrations of up to
10 mg/m3 polyacrylate-coated amorphous silica did not
lead to any biologically relevant changes of BALF pa-
rameters at any time point (Table 3; and Additional file
1: Table S1, Additional file 1: Table S4), nor were there
any changes in hematology parameters or in the acute
phase proteins in the blood. However, absolute spleen
weights were increased by 37% and 30% in animals ex-
posed to 2 and 10 mg/m3 SiO2.acrylate, respectively, and
their relative spleen weights were increased by 35% and
26%, respectively. By contrast, the absolute and relative
spleen weights of the recovery groups were comparable
to the corresponding control values. The increased
spleen weights of the exposure groups were assessed as
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was small. No morphological changes were detected in
the lung upon histopathological evaluation.
In following up the recorded alterations in spleen
weights, the lungs and spleens from three animals, each,
from the control and high concentration groups were in-
vestigated by transmission electron microscopy. In the
lung, electron-dense aggregates consisting of small
(approx. 20 nm) particles were recorded in the alveolar
space of the exposed animal with no corresponding find-
ings in the control animals (images not shown). In the
spleen of the animals treated with 10 mg/m3 SiO2.acrylate,
thrombocyte accumulations were observed (Figure 4B)
whereas the spleens of the control animals were un-
affected (Figure 4A). Additionally, the cytoplasm of the
splenetic lymphocytes seemed to be less homogenous in
the exposed animals (Figures 4C and 4D) than in the con-
trol animals (Figure 4E), and small electron-dense aggre-
gates were found within the lymphocytic cytoplasm of the
treated animals (Figures 4D and 4F). Since silicon particles
were detected in the spleen (for details on the outcome of
the organ burden analysis, c.f. Organ burden analysis),
these morphological changes were assessed as being re-
lated to the test material, even though the physiological
meaning of the findings in the spleen remains unclear.
Overall, the NOAEC for local effects in the respiratory
tract was assessed as being at least 10 mg/m3. Taking
into account the findings recorded for the spleen, the
NOEC for systemic effects was 0.5 mg/m3.
Other surface-coated amorphous silica (SiO2.PEG,
SiO2.phosphate, and SiO2.amino) No adverse effects
were observed after inhalation exposure to the three sil-
ica particles surface-modified with polyethyleneglycol
(SiO2.PEG), phosphate (SiO2.phosphate), or amino
groups (SiO2.amino) at concentrations up to 50 mg/m
3
(Table 3; and Additional file 1: Table S1, Additional
file 1: Table S4). Therefore the NOAEC for these com-
pounds was assessed as being at least 50 mg/m3.
In comparing the effects elicited by the surface-coated
silicas with those caused by naked amorphous silica, sur-
face modifications apparently mask the toxicity of the
core material.
Barium sulfate (BaSO4)
Nano-BaSO4 did not induce any treatment-related effects
up to an aerosol concentration of 50 mg/m3 (Table 3; and
Additional file 1: Table S1, Additional file 1: Table S5).
Only in the tissue homogenates of the lavaged lungs, a
transient increase in IL-1α was observed that was assessed
as not being biologically relevant. Therefore, the NOAEC
for BaSO4 was determined as being at least 50 mg/m
3.
These results stand in line with a previous study investi-
gating BaSO4 effects upon intratracheal instillation [25],where bolus doses of 4.8 mg per rat lung did not affect
any parameters of the BALF. Subchronic inhalation
exposure to an even higher concentration (75 mg/m3) of
micron-scale BaSO4, resulting in a lung burden of
5 mg/lung, also did not result in increased PMN counts in
the BALF [26]. Whereas the authors attributed this lack of
effects to the small surface area of fine BaSO4 (3.13 m
2/g),
micron-scale TiO2 (with a similar surface area of 6 m
2/g)
elicited pronounced increases of PMN neutrophils in the
BALF in the same concentration range [27].
Zirconium dioxide-based compounds
Nano-zirconium dioxide (nano-ZrO2) Inhalation ex-
posure to aerosol concentrations of up to 10 mg/m3
nano-ZrO2 did not induce any treatment-related effects
in cytological, protein, enzyme, cytokine or chemokine
levels in the BALF or in cytokine levels in the lung tissue
(Table 3; and Additional file 1: Table S1, Additional file 1:
Table S5), even though the comprehensive panel of 68 cell
mediators was assessed both in the BALF and lung tissue
(c.f. Summary of results). Likewise, the hematological pa-
rameters and acute phase protein levels in the blood
remained unchanged. There were no histopathological
changes of the respiratory tract, and cell proliferation rates
and apoptotic reactions in lungs cells were comparable to
those from the control groups (data not shown). Thus, the
NOAEC for nano-ZrO2 was assessed as being 10 mg/m
3.
This finding stands in line with human data for both
ZrSiO4 and ZrO2. In an occupational setting, 32 hand
finishers of zirconium metal, who were exposed to
5.75-14.7 mg/m3 of dust (25% zirconium) over pe-
riods of 1–17 years, did not develop any exposure-
related symptoms [28]. Similarly, a study following up
zirconium compound-exposed workers revealed that even
long-lasting exposure of up to 20 years to peak concentra-
tions up to 30 mg/m3 zirconium neither elicited abnormal
chest radiographs, nor did it impair lung function parame-
ters [29]. Hence, the lack of effects of nano-ZrO2 observed
in the present study may be due to the very low intrinsic
toxicity of this material.
Surface-coated zirconium dioxide (ZrO2.TODA, and
ZrO2.acrylate) No adverse effects were observed after
inhalation exposure to the surface-coated zirconium di-
oxides ZrO2.TODA or ZrO2.acrylate at concentrations
up to 50 mg/m3 (Table 3; and Additional file 1: Table S1,
Additional file 1: Table S5). Under the conditions of the
present study, the NOAEC for these compounds was
therefore at least 50 mg/m3.
Cerium dioxide-based materials
Nano-cerium dioxide and Al-doped nano-cerium di-
oxide Overall, nanoform cerium dioxide (nano-CeO2)
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spect to BALF cytology and mediators.
At aerosol concentrations of 0.5 mg/m3 nano-CeO2,
PMN neutrophil counts, total protein concentration and
macrophage colony stimulating factor (M-CSF) levels
were increased in the BALF. Inhalation exposure to 2.5
and 10 mg/m3 nano-CeO2 increased PMN neutrophil
and lymphocyte counts in the BALF immediately after
the final exposure, whereas macrophage counts were
reduced in comparison to the corresponding control
values (Table 3; Figures 3E and 3F; and Additional file 1:
Table S1, Additional file 1: Table S6). Several enzyme ac-
tivities (LDH, GGT, ALP) were increased in the BALF in
the 2.5 and 10 mg/m3 exposure groups, whereas NAG
activities and total protein levels were only increased at
10 mg/m3. Among the 68 antigens assessed in the BALF,
the level of monocyte chemoattractant protein-1 (MCP-
1) was prominently increased (approx. 20- to 25-fold
over the corresponding control values), while M-CSF
and CINC-1 levels were only moderately elevated (below
10-fold). The macrophage markers macrophage-derived
chemoattractant (MDC) and myeloperoxidase (MPO)
were increased 360-fold and 115-fold, respectively. After
the three-week post-exposure period, a partial regression
of these effects was observed (Table 3; Figures 3E and
3F; and Additional file 1: Table S1, Additional file 1:
Table S6).
Also in the lung tissue homogenates, of the 68 anti-
gens assessed, 9 cytokines and chemokines (i.e. CINC-1/
IL-8; keratinocyte cytokine/growth-regulated oncogen-α
(KC/GROα); MCP-1; MCP-3; M-CSF; MDC; macro-
phage inflammatory protein (MIP-1α); MIP-2; neutro-
phil gelatinase associated lipocalin (NGAL)) were
significantly increased in the 2.5 and 10 mg/m3 nano-
CeO2 exposure groups, and increases only partially
regressed within the post-exposure period (Additional
file 1: Table S1, Additional file 1: Table S7).
Al-doped nano-CeO2 also induced significant in-
creases in total cell counts, PMN neutrophil counts, and
total protein concentration, and elevations in all en-
zymes tested. In the BALF, Al-doped nano-CeO2 further
elicited higher concentrations of OPN than nano-CeO2,
but lower levels of M-CSF, and, in the lung tissue,
higher levels of IL-1α (nano-CeO2 data for OPN and IL-
1α, being insignificant, not shown). The extent of partial
regression of the elevated lung parameters was compar-
able in the recovery groups treated with either nano-
CeO2 or Al-doped CeO2 (Table 3; and SI, Additional
file 1: Tables S8 and S9).
Hematology parameters and acute phase protein levels
in the blood were not affected in rats treated with either
CeO2 compound. Histological examination of the
nano-CeO2 test groups revealed particles in alveolar
macrophages in the exposure and recovery groups and,additionally, in the recovery groups, mild diffuse or
multifocal alveolar histiocytosis. In the exposure groups
treated with Al-doped nano-CeO2, single or aggregated
particle-loaded alveolar macrophages were observed that
were still present after the post-exposure period, though
less frequently (SI, Additional file 2: Tables S14 and S15).
Cell proliferation rates and apoptosis in rats exposed to
nano-CeO2 were comparable to the rates recorded in the
corresponding control groups (data not shown).
Overall, inhaled nano-CeO2 and Al-doped nano-CeO2
caused a transient, concentration-dependent inflammation
of the lung at all concentrations. Based upon the changes
recorded in the BALF, the concentration-response curve
of Al-doped CeO2 was steeper than the one calculated for
nano-CeO2. In vitro studies with alveolar macrophages
performed within the German NanoCare project deter-
mined a higher biological activity for Al-doped CeO2 than
for nano-CeO2 [25], an observation that is in agreement
with the in vivo STIS results of the present study. Taking
into account the increased PMN neutrophil counts in the
BALF, a NOAEC could not be established for nano-CeO2
or Al-doped nano-CeO2 (NOAEC < 0.5 mg/m
3).
These results stand in line with the outcome of a pre-
vious study investigating CeO2 effects upon intratracheal
instillation of [16], showing that already bolus doses as
low as 0.15 mg/kg body weight – corresponding to the
low aerosol concentration of 0.5 mg/m3 applied in the
present STIS - affected BALF parameters.
Organ burden analysis
The lungs (Table 4) and mediastinal lymph nodes
(data not shown) were examined for the contents of the
respective main element of the test material. For most
test substances, the recorded pulmonary deposition was
consistent with the expected deposition calculated mak-
ing use of the Multiple Path Particle Dosimetry Model
(MPPD software, version 2.11) [30,31]. The decrease in
lung burden during the post-exposure period was
around 20% for most test substances, reflecting a clear-
ance rate with a half-life of about two months. For
nano-ZrO2, BaSO4, the SiO2 test substances (apart from
SiO2.acrylate), micron-scale ZnO and coated nano-ZnO,
the decrease rates were markedly higher: For nano-
ZrO2, decreases of up to 75% were observed. In animals
exposed to BaSO4, the lung burden decreased by 77%
during the three-week post-exposure period without
notable increase of the substance in the lung-draining
lymph nodes. Amorphous silica seemed to be cleared
quickly as well: For naked amorphous silica, SiO2.PEG,
and SiO2.amino, about 40 to 60% of the total deposition
were cleared within 3 weeks. Unlike the PEG and amino
coatings, however, the polyacrylate coating seemed to
hamper the clearance rate of SiO2. The most pro-
nounced decrease was recorded for those animals
Table 4 Measured test substance deposition in the lung, expected deposition calculated by the Multiple Path Particle




















% Decrease of lung
burden after
recovery perioda
Coated nano-TiO2 (T-lite SF™
containing 82% TiO2 and
10% Al(OH)3)
3.85 459.0 ± 71.3 (TiO2) 49.1 ± 7.6
(Al(OH)3)
12.4%b 19.1% 467.4 ± 43.4
(TiO2) 46.3 ± 5.0
(Al(OH)3)
+1%
Micron-scale ZnO 5.508 82.3 ± 12.5 1.5% 10.3% 27.1 ± 1.5 n.a.
Coated nano-ZnO
(NM-111)
0.216 33.9 ± 7.0 15.7% 12.4% 25.4 ± 1.3 n.a.
1.008 123.4 ± 28.4 12.2% 13.5% 26.3 ± 1.5 n.a.
4.968 428.2 ± 19.4 8.6% 13.4% 28.4 ± 4.1 n.a.
SiO2.naked 18.936 342.3 ± 10.7 1.8% 5.1% 208.2 ± 16.1 −39%
SiO2.acrylate
0.216 18.6 ± 6.2 8.6% 7.1% 15.7 ± 6.9 −16%
0.756 37.1 ± 6.9 4.9% 7.9% 30.0 ± 7.7 −19%
3.492 200.0 ± 30.9 5.7% 6.8% 132.1 ± 43.3 −34%
SiO2.PEG
0.738 59.2 ± 11.0 8.0% 8.8% 25.7 ± 2.1 −57%
3.60 182.6 ± 27.1 5.1% 8.8% 117.0 ± 45.7 −36%
19.476 834.3 ± 206.3 4.3% 6.5% 370.8 ± 40.5 −56%
SiO2.phosphate
1.044 71.3 ± 11.0 6.8% 10.9% 47.8 ± 3.3 −33%
3.60 194.7 ± 11.9 5.4% 6.1% 104.8 ± 21.4 −46%
18.54 499.2 ± 30.9 2.7% 6.2% 303.8 ± 91.1 −39%
SiO2.amino
0.756 87.0 ± 14.2 11.5% 10.5% 52.1 ± 9.6 −41%
3.672 295.9 ± 81.7 8.1% 5.3% 154.7 ± 25.7 −48%
18.144 741.6 ± 157.7 4.1% 5.4% 474.2 ± 155.1 - 36%
Nano-BaSO4 (NM-220)
c 19.224 1055.7 5.5% 9.6% 239.7 −77%
Nano-ZrO2
0.18 18.0 ± 5.6 10.0% 7.3% 6.8 ± 3.6 −62%
0.936 20.3d 117.5 2.2% 12.6% 8.2% 29.3 ± 6.2 −75%
3.456 270.6 ± 28.9 7.8% 6.7% 157.6 ± 19.0 −42%
ZrO2.TODA
0.720 83.3 ± 6.4 11.6% 10.9% 41.9 ± 5.4 −50%
3.816 233.2 ± 6.9 6.1% 10.9% 87.3 ± 62.8 −63%
18.792 693.4 ± 121.8 3.7% 7.7% 520.5 ± 82.0 - 25%
ZrO2.acrylate
0.684 7e 1.0% 16.0% LOQ
3.636 70 1.9% 11.1% 49 - 30%
18.18 169 0.9% 7.7% 190 + 12%
Nano-scale CeO2
0.277 52.0 ± 5.0 18.8% 16.6% 44.2 ± 4.4 −15%
1.069 165.8 ± 18.4 15.5% 14.3% 157.6 ± 18.7 −5%
4.176 417.6 ± 44.3 10.0% 15.4% 470.9 ± 51.2 +13%
Al-doped nano-scale CeO2
c 3.312 326.8 7.8% 6.8% 304.7 −7%
n.a.: Not applicable: Zn content returned to control levels in all concentration groups. No relative decrease of lung burden was calculated due to high
endogenous content of Zn.
LOQ: limit of quantification.
aRecovery period for SiO2.acrylate was 14 days after the final exposure. For all other substances, the recovery period was 21 days.
bTotal amount of TiO2 and Al(OH)3 was assumed as total deposition.
cOnly one rat was examined.
dOnly two samples were examined which differed considerably and hence are presented as individual animal data.
eData for one animal, LOQ in the other two.
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exposure period, the measured Zn content returned to
the control level in all test groups. This observation can
be explained by the dissolving properties of zinc oxide.
Overall, only very small amounts of the test substances
were found in the lung-draining lymph nodes (data
not shown). In animals exposed to either of the ZrO2
materials, zirconium was not detectable at any time
point in any of the examined animals. In animals ex-
posed to nano-CeO2 or Al-doped nano-CeO2, cerium
levels were below the detection limit in the exposure
groups. In the recovery group, they were 1.4, 2.5, and
4.1 μg nano-CeO2, respectively, for the 3 examined rats ex-
posed to 10 mg/m3 (effective concentration 11.6 mg/m3)
of this test material, and 2.2 μg for one animal treated with
10 mg/m3 (effective concentration 9.2 mg/m3) Al-doped
CeO2. Similarly, barium was not detectable in the lymph
nodes of the exposure groups and was only 1.4 μg in the
high concentration recovery group exposed to 50 mg/m3
BaSO4. Comparable amounts of zinc were found in the
lung-draining lymph nodes regardless of the applied test
concentration or the time point of assessment. Upon inhal-
ation exposure to nano-TiO2, test substance translocation
to the lung-draining lymph nodes was much lower than it
had previously been observed after exposure to high con-
centrations of micron-scale TiO2 or quartz [27].
In those animals exposed to coated nano-TiO2, BaSO4,
Al-doped CeO2, nano- or micron-scale ZnO, the liver,
kidneys, spleen, and brain (including the olfactory
bulb) were also examined for the content of the respect-
ive main element, with a detection limit of 500 ng/tissue
sample (data not shown). In all organs evaluated, the
titanium content was below this detection limit. Hence,
there was no indication for test substance translocation
upon inhalation exposure to coated nano-TiO2. The
contents of barium or cerium detected in the liver, as
the only extra-pulmonary organ, might be associated
with BaSO4 or CeO2 dissolution in the body [26,32].
Also zinc oxide is known to be soluble in the body [33].
Therefore some degree of transport of zinc ions to per-
ipheral organs was to be expected. Notwithstanding, the
background level of Zn was high in all animals of the
control group (20 μg/lung; 300 μg/liver), and the Zn
content determined in the organs of the animals treated
with coated nano-ZnO and micron-scale ZnO was indis-
tinguishable from the respective background levels de-
termined in the control animals (data not shown).
As regards translocation of inhaled SiO2.acrylate to
extra-pulmonary organs, small particle aggregates (60–
80 nm) were present in the cytoplasm of lymphocytes of
the white pulp of rats exposed to 10 mg/m3 SiO2.acrylate
(as evidenced by TEM; Figures 4C, 4D, 4F; c.f. Amorphous
silica-based materials). Using energy dispersed x-rayspectroscopy (EDX), these particles were identified as be-
ing silicon-rich, whereas the surrounding cytoplasm con-
tained only low background levels of silicon (Figure 4F).
Summary of results
In summary, the present study investigating the effects
of 13 nanomaterials or micron-scale ZnO upon inha-
lation exposure to rats at aerosol concentrations of ty-
pically 0.5 to 50 mg/m3 for five consecutive days (6 h/day)
revealed the following findings (Table 3):
 Eight nanomaterials (BaSO4, SiO2.acrylate, SiO2.PEG,
SiO2.phosphate, SiO2.amino, nano-ZrO2, ZrO2.TODA
and ZrO2.acrylate) did not elicit effects on the rat lung,
and their (local pulmonary) NOAECs were at least
50 mg/m3 (or at least 10 mg/m3 if this was the highest
concentration tested).
 SiO2.naked, multifocal macrophage aggregates were
observed in the respiratory tract immediately after
the exposure period that exacerbated towards a slight
multifocal inflammation during the 3-week post-exposure
period. Its NOAEC was 2.5 mg/m3.
 Four nanomaterials (coated nano-TiO2, coated nano-
ZnO, nano-CeO2, Al-doped nano-CeO2) evoked
transient and concentration-dependent pulmonary
inflammatory reactions that were only partially reversible
during the two- or three-week post-exposure period.
Their NOAEC was 0.5 mg/m3 or below. The same
applies to micron-scale ZnO, for which, however, no
NOAEC was laid down since it was only tested at
one (high) test substance concentration.
 Observed extra-pulmonary effects, immediately after
the final exposure, were the splenetic alterations
recorded for SiO2.acrylate (for which therefore a systemic
NOEC was set at 0.5 mg/m3) and the moderate to
severe necrosis of the olfactory epithelium recorded
for micron-scale ZnO and coated nano-ZnO. These
splenetic effects were fully reversible within the post-
exposure period, and the nasal cavity alterations par-
tially reversible.
Discussion
In 2009, the short-term inhalation study protocol (STIS)
was established to fulfil the urgent need for a rapid and
reliable method to evaluate the pulmonary toxicity of
nanomaterials [1]. The protocol was based on the hy-
pothesis that a nanomaterial’s toxicity (1) is initiated by
its inflammatory potential and (2) is influenced by its de-
position and translocation in the body and its clearance
therefrom. Both aspects can be determined after a rela-
tively short exposure period when including specific in-
vestigations of the animals. Meanwhile, more than 20
industrially relevant nanomaterials have been tested in
the STIS, covering the 13 nanomaterials presented in
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cadmium-based quantum dots [36,37], one polyacrylate
[38], and one pigment [Ma-Hock and co-workers, un-
published observations]. In the following section, the ex-
periences gained with all STIS conducted so far are
assessed with the aim of re-evaluating the study design
of the STIS and of determining its relevance in predic-
ting nanomaterial effects that develop upon subchronic
or chronic exposure.
Study protocol
The study design for the current STIS was first endorsed
based on an evaluation of an extensive data set for
nano-TiO2 [1]. Since then, the key elements of the study
design have remained unchanged, i.e.:
 Male Wistar rats;
 Head-nose inhalation exposure;
 Exposure for six hours a day on five consecutive days;
 Histological examination and bronchoalveolar
lavage;
 Post-exposure period of three weeks.
With regard to histological examination, experience
has shown that it is essential to evaluate the entire re-
spiratory tract. First of all, lavage parameters only reveal
pulmonary effects. Hence, effects occurring in the upper
respiratory tract might be missed without histological
examination. Coated nano-ZnO and micron-scale ZnO
are examples for substances affecting the upper respira-
tory tract. Additionally, classical BALF parameters are
general indicators of acute inflammatory reactions,
which are not necessarily associated to a specific type of
morphological change. For all of the above-mentioned
nanomaterials tested in the STIS so far, the pattern of
BALF changes has been similar: The number of PMN
neutrophils was the most sensitive parameter and was
accompanied by increases of other BALF cells, increased
BALF total protein concentrations and increased enzyme
activities. Notwithstanding these very similar BALF
findings, the spectrum of different nanomaterials in-
vestigated elicited clear differences in morphological
changes of the lung tissue, to name multiwall carbon
nanotubes (MWCNTs) as a prominent example [34,35].
Consequently, histological examination of the entire re-
spiratory tract should be an integral part of the STIS
protocol.
In in vitro studies, pro-inflammatory cytokines are
being widely applied as indicators of acute or on-going
inflammation or inflammation-like responses. Addition-
ally, pro-fibrotic cytokines, such as transforming growth
factor (TGF)-β1, M-CSF, or OPN, may be useful in iden-
tifying particle-induced fibrotic or neoplastic changes
already at very early pathogenic stages. Aiming atrecognizing appropriate markers for in vivo studies, such
as the STIS, almost 70 different cytokines, chemokines
and inflammation-relevant enzymes from the BALF and
lung tissue homogenates have been screened in the
course of the development of the STIS. Of these media-
tors, only a limited panel appear to be relevant for the
assessment of particle effects in the lungs. Specifically, 4
mediators, i.e. MCP-1, CINC/IL8, M-CSF and OPN,
were selected as being most meaningful for the detection
of substance-induced pulmonary reactions in the BALF.
MCP-1 and CINC-1/IL-8, both of which are released
by epithelial cells and, to a certain extent, also by macro-
phages, reached considerable concentrations in the
BALF upon particle treatment. MCP-1 is a C-C cytokine
that strongly attracts blood monocytes and lymphocytes
to the alveolar compartment [39]. CINC-1, the rat
homologue to IL-8, is a pro-inflammatory C-X-C che-
mokine that exhibits neutrophil chemotactic activity
[40]. Dose-dependent increases of MCP-1 and CINC-1/
IL-8 in the BALF were recorded upon inhalation expos-
ure to nano-CeO2, Al-doped nano-CeO2, coated nano-
ZnO, or micron-scale ZnO. Apart from the dose groups
treated with coated nano-ZnO, the increases in MCP-1
exceeded those of CINC-1/IL-8.
Reporting increased IL-8 expression in human A549
alveolar epithelial cells upon exposure to micron-scale
BaSO4 (and similar observations published by Tran et al.
[13]), Donaldson et al. [40] suggested IL-8 induction as
being a relevant parameter for the validation of in vitro
assays. However, in contrast to the observations made by
Donaldson and co-workers, in the present study, up to
50 mg/m3 nano-BaSO4 did not lead to any biologically
relevant cytokine induction. This discrepancy might be
explained by differences of the BaSO4 materials or by
deviating experimental regimes. Nevertheless, it should
be followed up in further studies aiming at correlating
in vivo responses to in vitro IL-8 production in epithelial
cells. Regardless of any possible in vitro-in vivo discrep-
ancies, both MCP-1 and CINC/IL-8 displayed a large dy-
namic range in the present study, and hence were
assessed as suitable markers for early pulmonary inflam-
mation and macrophage recruitment to the lungs.
M-CSF is a cytokine produced by macrophages that is
involved in the differentiation of monocytes into histio-
cytes or, in conjunction with other factors, in the differ-
entiation of osteoclasts [41]. At least in mice, its over-
expression has been associated with glycolipid-induced
granulomas [42], and M-CSF might possibly induce an
increase in the number of alveolar macrophages. In the
present study, M-CSF levels were not elevated upon ex-
posure to nano-BaSO4, or polyacrylate-coated amorph-
ous silica, while pronounced M-CSF increases were
elicited by coated nano-ZnO and micron-scale ZnO, and
nano-CeO2. However, the M-CSF concentrations in the
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BALF, presumably due to the lavage technique used,
allowing only small fractions of alveolar macrophages to
be washed out.
OPN is an arginine-glycine-aspartic acid (RGD)-con-
taining protein occurring not only in the extracellular
matrix of mineralized tissues, but also as a cytokine in
body fluids [43]. OPN transcription is, among others,
stimulated by IL-1 and/or TNF-α. As a cytokine, OPN
has both pro- and anti-inflammatory properties. With
respect to the latter, it inhibits production of nitric oxide
(NO) and down-regulates inducible NO synthase [44].
More specifically, OPN has been described to be in-
volved in pulmonary granuloma formation in rodents
[45,46]. In rats exposed subchronically to 50 mg/m3
micron-scale TiO2, a concentration eliciting lung in-
flammation and fibrosis [7], immediate and sustained
formation of OPN was observed. These and other re-
sults strongly suggest that OPN is a useful biomarker
for fibro-proliferative lung disease in rodents and
humans [47].
In the present study, OPN was increased up to 10-fold
directly after inhalation of nano-CeO2, coated nano-
ZnO, and micron-scale ZnO. In all of these cases, OPN
increases were transient, and they were accompanied by
elevations of other pro-inflammatory cytokines, such as
MCP-1 or IL-1α. Even though the corresponding histo-
logical examinations revealed no signs of beginning
granulomatous changes or fibrosis, Cho and co-workers
[9] recorded the development of granulomas and depos-
ition of fibrotic tissue, respectively, upon instillation of
CeO2 or ZnO nanoparticles. By contrast, the slight in-
crease in OPN observed after the three-week post-
exposure period in the recovery group treated with SiO2.
naked was not accompanied by changes in any other
cytokines and, therefore, was assessed as being arbitrary.
Aiming at supplementing evaluation of the BALF, the
added value of determining TNF-α and IL-1α as lung
tissue homogenate parameters was assessed. TNF-α and
IL-1α are pro-inflammatory cytokines released by acti-
vated macrophages and other immune cells. By auto-
crine and/or paracrine pathways, they can stimulate
release of further chemokines from other macrophages
or epithelial cells [48-50]. TNF-α is a pleiotropic cyto-
kine and a strong chemoattractant for PMN neutrophils
[50,51]. Therefore it contributes to the early PMN neu-
trophilic infiltration and eosinophil recruitment into the
airways, and it further increases alveolar capillary perme-
ability [51,52]. In previously performed STIS, both IL-1α
and TNF-α were found in higher concentrations in lung
tissue homogenates than in the BALF. This may be ex-
plained by IL-1α also being synthesized by epithelial
and endothelial cells and/or by the observation that
approximately 80% of the pulmonary macrophagesremain in the lung after the first lavage [53]. In all
STIS performed in the course of the present study,
only small and inconsistent increases in TNF-α or IL-
1α levels were observed in the BALF or lung tissue
homogenates, and these minor changes were found to
add only limited information to the understanding of
substance-induced early inflammatory processes occur-
ring in the lung.
Similarly, also the assessment of cell proliferation rates
or apoptosis in the large and medium bronchi, terminal
bronchioli, or alveoli did not provide substantial added
value information for the toxicological assessment of the
test materials investigated in the present study.
Correlation of the STIS with chronic or subchronic
inhalation studies
In an extensive case report by Klein and co-authors [3],
the results of all STIS that were available at the time of
writing in 2012 were compared to the results of sub-
chronic and chronic inhalation studies of the same or
similar materials. The review also included the overall
results of a few of the STIS presented and discussed in
detail in the study at hand. The list of materials assessed
by Klein and co-authors comprises commercially rele-
vant nanomaterials and selected non-nanoform reference
materials, i.e. quartz, pigmentary and nanosized TiO2, syn-
thetic amorphous silica, zinc oxide, zirconium dioxide, and
multiwall carbon nanotubes. The studies included in the
case report were not identical in regard to experimental
conditions, such as animal strains, physico-chemical char-
acteristics of the test materials, or preparation of the test
material. Furthermore, only a limited number of sub-
chronic and chronic studies were available against which
to compare the results of the STIS. Nevertheless, the
ranking of the spectrum of nanomaterials in regard to
their potential to induce adverse effects was concordant
for the NOAECs determined in the STIS and in the
corresponding subchronic and chronic studies, and it
was also consistent with the ranking set up in the
present study. Furthermore, the STIS were able to reveal
the progression or regression of adverse effects, to indi-
cate translocation of materials to extra-pulmonary organs
and to provide early indications of effects that only de-
velop over time and hence only become fully pro-
nounced in longer-term studies [3].
Overall, the STIS is able to detect early effects that
mostly reflect inflammation, and/or beginning histo-
logical changes, while a meaningful comparison of
subchronic toxicity endpoints, such as fibrosis and
cancer, to STIS parameters is hardly possible. Never-
theless, sustained inflammation is being suspected to
be a necessary, though not sufficient, prerequisite for
enhanced reactive oxygen species (ROS) formation, fi-
brosis and even cancer, at least in the rat lung [54].
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an early stage (directly after the final exposure or
two days thereafter) combined with data on revers-
ibility of the effects (three weeks post-exposure) may
be used as an indicator for the severity of toxic
effects.
Taking into account all of these considerations, the
STIS is assessed as a suitable test method to be applied
as a versatile first step in a tiered testing approach.
As an early tier test, the STIS enables prioritizing
nanomaterials for further testing and allows selecting
appropriate testing strategies for the given test sub-
stance, which may, or may not, include subchronic
or chronic tests. In the report of the NanoSafety
Cluster Working Group 10, application of a targeted
strategy for the testing and assessment of nanoma-
terials was encouraged, and the STIS was suggested
as a basic test for Tier 2, i.e. the first tier requiring
testing, upon collection of all available information
in Tier 1 [55].
Application of the STIS data for the grouping of
nanomaterials
The STIS provides information on the lung burden, test
substance translocation to extra-pulmonary organs, as
well as the type and potency of effects in the lung and in
other tissues together with the persistence of these
effects. Making use of these elements of the STIS proto-
col, the 14 materials (13 nanomaterials) assessed in the
present study can be grouped in accordance to (1) the
potency of pulmonary inflammation; (2) the affection of
extra-pulmonary organs; (3) the reversibility or persist-
ence of effects.
Nanomaterial grouping based on the potency of lung
inflammation
Based on the pulmonary effects observed at different aero-
sol concentrations in the STIS, the test materials evaluated
in the present study (and in previously performed STIS)
can be assigned to four different potency groups
(Figure 5):
 Substances causing no lung effects in the STIS up to
aerosol concentrations of 50 mg/m3, i.e. SiO2.PEG,
SiO2.phosphate, SiO2.amino, BaSO4, nano-ZrO2,
ZrO2.TODA, ZrO2.acrylate. In further STIS, graphite
nanoplatelets and carbon black did not induce any
adverse effects up to the highest test concentration
10 mg/m3 [35]. SiO2.acrylate did not cause
any pulmonary effects up to the highest
concentration of 10 mg/m3, but it did elicit
splenetic effects at 2 mg/m3 and above, so that
a systemic NOEC of 0.5 mg/m3 was determined
for this substance. Substances causing lung effects in the STIS at
aerosol concentrations at 2.5 mg/m3, i.e. precipitated
naked amorphous silica;
 Substances causing lung effects in the STIS at
aerosol concentrations of approximately 0.5 mg/m3,
i.e. uncoated nano-TiO2 [1], coated nano-TiO2,
ZnO, coated nano-ZnO, nano-CeO2, Al-doped
nano-CeO2;
 Materials causing lung effects in STIS at
approximately 0.1 mg/m3: None of the 14 test
materials applied in the present study was tested at
such low aerosol concentrations, since they were not
expected to possess a very high toxic potency. For
MWCNTs, however, a NOAEC at or below 0.1 mg/m3
was calculated in a STIS, and this very low value
was subsequently confirmed in two unrelated
subchronic inhalation studies [35,56].
Of note, this STIS-based potency ranking is largely
consistent with a banding scheme suggested by the US
National Institute for Occupational Safety and Health
(NIOSH) [59].
Based on the toxic potency information obtained in
the STIS, CeO2 and BaSO4 nanomaterials were selected
for 2-year combined chronic toxicity/carcinogenicity in-
halation studies that are still ongoing (OECD TG 453).
Nanomaterial grouping based on affected extra-pulmonary
organs
Of the 13 nanomaterials tested in the STIS in the
present study, only two caused effects outside the lung.
These were the same materials that were also detected
in extra-pulmonary tissues, i.e. polyacrylate-coated SiO2
and coated nano-ZnO. Inhalation of SiO2.acrylate re-
sulted in enlarged spleens, and ZnO caused damage of
the upper airways. These findings confirm the value of
collecting tissue burden data, and affection of extra-
pulmonary organs may also (and correspondingly) be
used as a parameter for grouping and testing strategies.
Based upon the results of the STIS, further testing of
these materials should include effects on target organs.
Nanomaterial grouping based on the reversibility or
persistence of effects
The pulmonary effects observed upon rat 5-day inhal-
ation exposure to coated nano-TiO2 or the ZnO and
CeO2 compounds were not fully reversible within the
three-week post-exposure period, whereas the systemic
effects caused by polyacrylate-coated SiO2 were no lon-
ger observed after this period. One reason for effects be-
ing only partially regressive might be that the three-
week post-exposure period was not sufficiently long to
allow full recovery to take place, such as is most likely
the case for the soluble ZnO materials. Particle solubility
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ibility of effects. Consequently, e.g., amorphous silica
nanomaterials having some (low) degree of solubility
would be less prone to elicit long-term effects than TiO2
nanomaterials for which particle dissolution has not
been recorded.
Alternatively, partial regression of effects might be an
indication that the development of chronic effects can-
not be excluded, especially if the lung clearance mechan-
ism is overloaded. Such specifications obviously provide
valuable information for the design of further investiga-
tions of these substances. Moreover, information on the
reversibility or persistence of effects, combined with sub-
stance pulmonary clearance rates, can be used as a
grouping criterion for hazard assessments addressing
short-term exposure scenarios. Likewise, progressive
pulmonary alterations, such as fibrosis upon inhalation
exposure to quartz or the formation of granuloma upon
exposure to MWCNTs [34,35], fall into this category.
Conclusion
Short-term inhalation studies with aerosols generated
from 14 particulate materials (1 micron-scale and 13
nanomaterials) provided information on the biokinetics
and pulmonary and extra-pulmonary effects of the test
materials. It further allowed ranking the materials in
regard to their potency based upon NOAECs that were
derived from well-quantifiable parameters, such as PMN
neutrophil counts or total protein concentrations in the
BALF, or from the incidence and severity of histological
findings (Figure 5).
A number of the test materials did not elicit adverse
pulmonary effects under the experimental conditions of
the present study, i.e. BaSO4, all ZrO2 materials and the
surface-functionalized SiO2 materials. With the excep-
tion of SiO2.acrylate, also no systemic effects were ob-
served for these substances. Hence, the outcome of the
present study points to the low pulmonary toxicity of
these nanomaterials upon inhalation.
Apart from serving to reveal a substance’s toxic po-
tency, information on the type, location and reversibility
of the observed effects can be used to guide further test-
ing, e.g. in regard to those materials for which adverse
pulmonary effects (nano-TiO2, both CeO2 nanomaterials
and SiO2.naked) or adverse extra-pulmonary effects
(both ZnO materials and SiO2.acrylate) were observed.
Additionally, the results from the STIS can be used for
the grouping of nanomaterials for safety assessment. It is
increasingly being recognized that it is not possible to
relate biological effects elicited by nanomaterials to one
single material property and that other forms of group-
ing might be more relevant in predicting nanomaterial
effects [55,59]. Groups of nanomaterials with similartoxicity can be defined based upon similarities in bio-
logical activities, lung tissue burden or translocation to
extra-pulmonary tissues, rather than merely referring to
the materials’ properties. In this context, the STIS data
published so far provide a large database on effects upon
inhalation exposure to nanomaterials that can serve to
foster the understanding of material properties, which
are attributable to toxic effects of nanoparticles.
Based upon the overall outcome of the present study,
the STIS is suggested as an early tier test in an inte-
grated approach to the testing and assessment of nano-
materials. As the comparison of the outcome of the
STIS with results from subchronic and chronic inhal-
ation studies has revealed, the STIS may well be suited
in reducing the need for such longer-term studies. Fur-
thermore, the STIS may be supplemented or even re-
placed by appropriate in vitro methods once they become
available. In this respect, STIS data will contribute to the
development and validation of such in vitro methods,
thereby directly serving the 3Rs principle to refine, reduce,
and, ultimately, replace animal testing as first described by
Russell and Burch in 1959 [60] and laid down as legal
provision in the European Directive 2010/63/EU on the
use of animals for scientific purposes [61].
Material and methods
Test materials
As presented in Table 1, the characterization of the ma-
terial properties included particle size distribution – in
the dry state and in relevant media; state of agglomer-
ation or aggregation, water solubility and dispersability,
crystalline phase, crystallite size, specific surface area,
zeta potential (surface charge), surface chemistry (where
appropriate), photocatalytic activity and porosity. The
applied characterization methods have previously been
described in detail together with a discussion of the
results of the physico-chemical characterization for the
powders [22] and the nanoGEM project suspensions
[23] (Table 5).
Aerosol generation and monitoring
Liquid nanomaterial dispersions were delivered at a con-
stant rate into an atomizer and aerosolized by compressed
air. For solid materials, dust aerosols were produced by
dry dispersion of powder pellets with a brush dust gener-
ator (developed by the Technical University of Karlsruhe,
Germany, in cooperation with BASF, Germany). The dif-
ferent target concentrations were achieved by adjustment
of the feeding speed of the substance pellet and the
rotation speed of the brush. Aerosols were generated
with compressed air and diluted with conditioned air.
The aerosols were passed via a cyclone (to separate
particles > 3 μm) into the head-nose inhalation system.


















Recovery period 21 14 21 21 21 21
Necropsy and histology of
respiratory tract
√ a √ b √ b √ b √ c √ a
Histology of brain n.d. √ b √ b √ b n.d. √ a
Cell proliferation and
apoptosis
n.d. n.d. √ b √ b n.d. n.d.
Electron microscopy n.d. √ a n.d. n.d. n.d. n.d.
BALF cytology, protein and
enzyme activitiesd
























in lavaged lung tissued







OECD TG 412; c-reactive
protein and haptoglobind
n.d. √ √ √ √ √
Organ burdena, f √ √ √ √ √ √
n.d.: not determined.
aFor these investigations, altogether 3 animals per concentration and time point were used.
bFor these investigations, altogether 6 animals per concentration and time point were used.
cFor this investigations, 3 animals per concentration and time point were used in the BaSO4 and Al-doped CeO2 test runs, whereas 6 animals per concentration
and time point were used in the SiO2.naked test run.
dFor these investigations, altogether 5 animals per concentration and time point were used.
ec.f. Evaluation of bronchoalveolar lavage fluid (BALF) and lung tissue homogenates.
fFor all test materials, tissue contents of the respective main element were determined in the lung and lung-associated mediastinal lymph nodes. For coated
nano-TiO2, BaSO4, Al-doped CeO2, nano- and micron-scale ZnO, additionally, organ burden of the extra-pulmonary organs was assessed.
Abbreviations: CINC-1/IL-8 cytokine-induced neutrophil chemoattractant-1, the rat homologue to IL-8, IL interleukin, M-CSF macrophage colony stimulating factor,
MCP, monocyte chemoattractant protein, MIP macrophage inflammatory protein, OPN osteopontin, TNF-α tumor necrosis factor-α.
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less steel were used, and the generator itself and all
conducting tubes were grounded [57,62].
The atmospheric concentration of the aerosols and the
aerodynamic particle diameter (cascade impactor analysis)
were determined by gravimetric measurement using a
sampling probe with a diameter of 7 mm. In general, the
sampling velocity was adjusted to 1.25 m/s, and the sam-
pling flow rate was 3 L/min. Under these conditions, the
sampling error due to an-isokinetic sampling is considered
to be negligible [62].
To determine the atmospheric aerosol concentration,
a sampling device (Millipore) equipped with glass fibre
filters (Macherey-Nagel, Düren, Germany, type MN 85/
90 BF, d = 4.7 cm) was used. Sampling was performed
adjacent to the location where the animals’ noses were
positioned in the exposure system. Depending on the
respective atmospheric concentrations, the sample vol-
umes ranged from 10–360 L to achieve a sample massof 1–5 mg per sample. The aerosol concentration was
calculated from the difference between the weight of the
pre-weighed filter (Sartorius M3P-000 V001 balance;
Sartorius, Germany) and the weight of the filter after
sampling with reference to the sample volume of the
aerosol. Two samples were drawn from each exposure
chamber on each exposure day (total 10 samples per
concentration over the 5-day exposure period). Means
and standard deviations were calculated from these 10
samples per concentration.
Aerosol particle characterization was performed with
an eight-stage Cascade Impactor (Marple Personal Cas-
cade Impactor; Sierra-Andersen, USA). The effective
aerodynamic cut-off diameters were 21, 15, 10, 6.5, 3.5,
1, 0.7, or 0.4 μm. A backup filter was used to collect par-
ticles smaller than 0.4 μm. A vacuum pump (Millipore;
Merck, Darmstadt, Germany) with a flow-limiting orifice
calibrated to 3 L/min (Millipore) was used for sampling.
The stages were weighed before and after sampling using
Figure 4 Transmission electron microscopy of the spleen. A: control animal, magnification 8000×; B: animal exposed to 10 mg/m3 SiO2.
acrylate, magnification 8000×. Image showing accumulation of large numbers of thrombocytes (arrows); C: animal exposed to 10 mg/m3 SiO2.
acrylate, magnification 8000×. The lymphocytic cytoplasm is less homogenous than that of the control animal. D: magnification (25 000×) of an
indicated sector of panel C, showing small electron-dense aggregates within the lymphocytic cytoplasm (arrows). E: Magnification (50 000×) of
lymphocytic cytoplasm of the control animal having a very homogenous structure. F: Animal exposed to 10 mg/m3 SiO2.acrylate, magnification
200 000×. Again, the lymphocytic cytoplasm is less homogenous than that of the control animal, and electron-dense particles are found within
the cytoplasm. By EDX analysis, the electron-dense particles were identified as being silicon-rich.
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balance (Mettler-Toledo, Germany). Sample volumes were
between 15 L and 720 L depending on their atmospheric
concentration.
Additionally, particle size distribution was measured
with a Scanning Mobility Particle Sizer (SMPS, model
3022A/3071A; TSI, USA). The SMPS system comprisedNo adverse effects observed up to the highest concentration
BaSO4, SiO2.PEG, SiO2.phosphate , SiO2.amino, nano.ZrO2, Z
SiO2.acrylate
graphite nanoplatelets low surface area carbon black 
Adverse effects observed at 10 mg/m3
SiO2.naked, graphene
nanostructured calcium silicate hydrate seeds 
Adverse effects observed at approx. 0.5 mg
nano-CeO2, Al doped nano-CeO2, coated n
uncoated nano-TiO2
NOAEC levels < 0.5 mg/m3 and
MWCNT quartz







Figure 5 Ranking of nanomaterials according to their toxic potency. N
Names of substances assessed in other studies are printed in italics and thea Model 3071A Electrostatic Classifier separating the
particles into known size fractions and a model 3022A
Condensation Particle Counter measuring particle count
concentrations. Particles in the size range from 0.015-
0.805 μm were measured with 32 size channels per de-
cade. The SMPS sampled at a frequency of 0.3 L/min,






tic NOEC at 0.5 mg/m3),
ames of substances presented in this paper are printed in bold.
corresponding reference is provided [1,11,35,57,58].
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at the inlet of the SMPS.
Finally, all aerosols were measured with an aerosol
spectrometer (WELAS 2000; Palas, Karlsruhe, Germany)
in which single particles are illuminated with a white-light
source. The measuring range of the sensor was 0.3-10 μm
and the sampling flow rate 5 L/min.
Animals
Permission for performance of the animal studies was
obtained from the local regulatory agencies, and all pro-
tocols stood in compliance with the respective federal
guidelines. Male Wistar (strain Crl:WI (Han)) rats
(7 weeks of age; specific pathogen free) were obtained
from Charles River Laboratories (Sulzfeld, Germany).
The laboratories of BASF’s Experimental Toxicology and
Ecology Unit, where all studies were performed, possess
an AAALAC accreditation (International Association for
Assessment and Accreditation of Laboratory Animal
Care). All procedures for animal care and exposure were
conducted in accordance with the provisions of the
German Animal Welfare Act (1998). For a few substances,
the animals were housed individually in mesh-floored
cages, whereas for the majority of the studies (that were
performed at a later time point), social housing was
applied (polysulfonate cages (H-Temp [PSU]), floor area
about 2065 cm2 (610×435×215 mm); supplied by TECH-
NIPLAST, Germany). All animals rooms were maintained
at 20-24°C, with a relative humidity of 30-70% and a light/
dark cycle of twelve h each. All animals were acclimatized
to these conditions for about two weeks before the onset
of the study. In home cages, the animals were allowed
free access to laboratory diet (Provimi Kliba SA, Basel,
Switzerland) and water, but not during the exposure
periods.
Study design
The male Wistar rats (c.f. Table 5 for the concrete num-
bers of animals used for the testing of the different ma-
terials) were exposed to test substance aerosols, or
conditioned air in the control groups, for six h per day
on five consecutive days by head-nose exposure. ‘Exposure
groups’ were euthanized shortly after the final exposure,
and ‘recovery groups’ after the three-week post-exposure
period (two weeks for SiO2.acrylate).
Bronchoalveolar lavage of 5 rats/test group was per-
formed, and the BALF was analysed, determining BALF
cytology, total protein, enzyme activities and (apart from
the test groups treated with coated nano-TiO2) BALF cy-
tokines and chemokines (described in detail in Evalu-
ation of bronchoalveolar lavage fluid (BALF) and lung
tissue homogenates). For a number of test substances,
cytokines and chemokines were additionally assessed in
tissue homogenates of the lavaged lungs (Evaluationof bronchoalveolar lavage fluid (BALF) and lung tissue
homogenates). The blood obtained from the 5 animals/
test group used for BALF collection (again apart from
coated nano-TiO2) was submitted to haematology and
clinical chemistry in accordance with the parameters
listed in OECD TG 412, and, additionally, c-reactive
protein and haptoglobin were assessed (Blood analysis).
Three or six animals from all test or control groups from
the exposure or recovery groups were submitted to nec-
ropsy and histopathological evaluation of the respira-
tory tract (Necropsy and histopathological evaluation).
For those test groups treated with micron-scaled or
coated nano-ZnO, nano-CeO2 or nano-ZrO2, cell prolif-
eration and apoptosis rates were determined in the
large and medium bronchi, terminal bronchioli, and
alveoli (Assessment of cell proliferation and apoptosis). In
those animals submitted to necropsy, organ burden was
determined, i.e. the content of the test materials in the
lung, in the mediastinal lymph nodes, and in the extra-
pulmonary organs (Organ burden analysis and TEM and
EDX organ analysis). In addition, the spleens of 3 rats,
each, of the highest dose group treated with SiO2.acrylate
as well as of the corresponding control group were sub-
mitted to transmission electron microscopic investiga-
tion and, for one spleen, each, to EDX analysis (Organ
burden analysis and TEM and EDX organ analysis).
The 13 nanomaterials and micron-scale ZnO were
tested over a period of four years with slightly differing
study designs for the different test materials (c.f. Table 5
for details on the study designs for each material and a
specification of the respective examinations performed
at different time points).
Evaluation of bronchoalveolar lavage fluid (BALF) and
lung tissue homogenates
The animals used for BALF collection were anesthe-
tized and exsanguinated, and the exposed lungs were
washed by two instillations of physiologic saline solution
(flow rate 12 ml/min; instillation volumes were adjusted to
the mean group body weight (0.9% (w/v), 6–8 ml/wash).
About 92% of the instilled solution was recovered as
lavage fluid per animal. The two washes were combined
and mixed prior to analysis. Aliquots of combined BALF
were used to determine total protein concentration, total
cell count, differential cell count, and activities of BALF
enzymes as well as mediator levels.
Total BALF cell counts were determined with an
Advia 120 (Siemens Diagnostics, Fernwald, Germany)
hematology analyzer. Counts of macrophages, PMN
neutrophils, lymphocytes, eosinophils, monocytes and
atypical cells were performed on Wright-stained cyto-
centrifuge slide preparations as described by [32]. The
differential BALF cell count was evaluated manually by
counting at least 400 cells per sample.
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917 (Roche Diagnostics, Mannheim, Germany) reaction
rate analyzer:
 Total protein (turbidimetric method with
Benzethonium chloride);
 Lactate dehydrogenase (EC 1.1.1.27; kinetic UV test,
340 nm, 37°C acc. to the International Federation of
Clinical Chemistry (IFCC) reference system of
enzymes);
 Alkaline phosphatase (EC 3.1.3.1; kinetic color test,
450 nm, 37°C acc. to IFCC);
 N-Acetyl-β-D-glucosaminidase (EC 3.2.1.30; color
test, 580 nm, 37°C; [63]);
 γ-Glutamyltransferase (EC 2.3.2.2, Szasz method
(kinetic color test), 415 nm, 37°C acc. to IFCC).
Aiming at determining cell mediators in the BALF that
were suitable in predicting substance-induced pulmonary
effects, an extensive panel of altogether 68 cytokines,
chemokines and inflammation-relevant hormones and
enzymes were assessed in the BALF from the test groups
treated with micron-scale ZnO, coated nano-ZnO, nano-
CeO2 or nano-ZrO2.
This panel of mediators comprised 67 antigens that were
assessed at Rules-Based Medicine, Inc. (Austin, TX, USA)
making use of the xMAP technology (Luminex Corp.,
Austin, TX, USA) as described previously [32,64-67].
These 67 antigens encompass the 58 antigens of the
Rodent Multi-Analyte Profile (RodentMAP® v. 3.0) and 9
additional antigens of the Rat KidneyMAP® v. 1.0 (c.f.
https://rbm.myriad.com/products-services/rodentmap-
services/ for full lists of the respective panels of media-
tors). CINC-1, the rat homologue to IL-8, was added to
this spectrum as a further, 68th cytokine, since it had
been recognized as relevant in detecting inflammatory
reactions in vitro [24,40]. CINC-1 was measured by
ELISA (Quantikine rat CINC-1, cat. no. RCN100; R&D
Systems, Inc., Minneapolis, USA).
Mediator inductions were assessed as being exposure-
related, if they were increased (1) in a concentration-
dependent manner; and (2) by at least 2-fold as com-
pared to the concurrent control value in the high dose
group on one of the study days. Mediator levels that
were below the respective detection limits were assessed
as being unchanged.
Upon evaluation of this large panel of 68 antigens, MCP-
1, CINC-1, M-CSF, and OPN were determined as being
most relevant for characterizing pulmonary inflammation
and therefore were selected for all subsequent BALF
evaluations. This restricted monitoring panel was also
arranged with the aim of covering different functional
groups of antigens, i.e. CC chemokines (MCP-1); CXC
chemokines (IL-8/CINC-1); hematopoietic cytokines(M-CSF); and inducers of proliferation of sessile cells
(OPN) [1].
These four chemokines and cytokines were measured
in-house using a sunrise MTP reader (Tecan AG,
Switzerland) with the Magellan Software provided by the
instrument producer, and making use of the following
ELISA test kits:
 MCP-1 (rat MCP-1; cat. no BMS631INST; Bender
MedSystems, Vienna, Austria)
 CINC-1 (Quantikine rat CINC-1, cat. no. RCN100;
R&D Systems Inc., Minneapolis, USA;);
 M-CSF (Quantikine mouse M-CSF, cat no. MMC00;
R&D Systems, Inc., Minneapolis, USA);
 OPN (Quantikine mouse OPN, cat. no.
MOST00R&D Systems, Inc., Minneapolis, USA).
In order to evaluate if antigens were washed out of
pulmonary cells into the BALF, antigens were also mea-
sured directly in tissue homogenates of the lavaged
lungs: After bronchoalveolar lavage, the right lung por-
tion of each animal was resected and stored at −80°C
until lung tissue homogenate preparation: 0.2 g of the
main lobe (lobus caudalis dexter) was mixed with 0.8 ml
ice-cold Tissue Protein Extraction Reagent (T-PER, cat.
no. 78510, Pierce Biotechnology, Rockford, IL, USA),
supplemented with Complete Protease Inhibitor Cocktail
(cat no., 11 873 580 001, Roche, Basel, Switzerland), and
homogenized for up to 40 s with an Ultra-Turrax (IKA,
Staufen, Germany). Finally, the resulting homogenate
was centrifuged at 14,000 g and 4°C for 5 min.
Also for the mediators in the lung tissue homogenates,
initial evaluations performed with lung tissues from the
nano-CeO2 and nano-ZrO2 test groups aimed at deter-
mining relevant parameters, and the broad panel of 68
mediators (see above) was investigated in the samples
from these test groups. The resulting comparison of
mediator levels in the BALF and the lung tissue homog-
enates revealed that for two mediators (i.e. IL-1α and
TNF-α), increases were consistently more pronounced
in the lung tissue than in the BALF. Therefore, these
two cytokines indicating local inflammation were inclu-
ded in the subsequent STIS (investigations of all SiO2
nanomaterials, BaSO4 and Al-doped nano-CeO2). The
following test kits were used:
 IL-1α (FlowCytomix rat IL-1α Simplex Kit; cat. no.
BMS8627FF; Bender MedSystems, Vienna, Austria),
measured with a FACS Calibur flow cytometer
(Becton Dickinson, Heidelberg, Germany) using the
instrument producer’s FlowCytomix Pro Software,
vs. 2.3.
 TNF-α (Quantikine rat TNF-α/TNFSF1A; cat. no.
RTA100R&D Systems Inc., Minneapolis, USA),
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Switzerland), using the instrument producer’s
Magellan Software.Blood analysis
Blood samples from five fasted rats per dose group were
collected in the mornings after overnight food with-
drawal by retro-orbital venous plexus puncture under
isoflurane anesthesia (Isoba®, Essex GmbH; Munich,
Germany). The following hematology parameters
were determined in the EDTA-stabilized blood with a
hematology analyzer (Advia 120, Siemens Diagnostics;
Fernwald, Germany): red blood cell counts, hemoglobin,
hematocrit, mean corpuscular volume (MCV), mean cor-
puscular hemoglobin content (MCH), mean corpuscular
hemoglobin concentration (MCHC), platelet counts, total
white blood cell and differential blood cell counts.
In addition, acute phase proteins were determined in
the serum:
 Haptoglobin (photometric assay based on the
preservation of the hemoglobin peroxidase activity
(Tridelta Ltd, Maynooth, Ireland)) was measured
using the COBAS Fara instrument (Roche, Basel,
Switzerland);
 C-reactive protein (ELISA; Becton Dickinson
Biosciences, Heidelberg, Germany);
 α2-macroglobulin (ELISA; Kamiya Biomedical
Company, Seattle, USA). The latter two were
measured with a Sunrise MTP Reader (Tecan AG,
Switzerland) using the Magellan Software provided
by the instrument producer.
In animals exposed to micron-scale ZnO or coated
nano ZnO, cell mediators were also measured in serum
to further assess possible systemic effects. For this pur-
pose, samples were sent to Rules Based Medicine, Inc.
(Austin, TX, USA), and the same panel of 67 antigens was
measured with xMAP technology (Luminex Corporation,
Austin, TX, USA), as described for the BALF samples.Necropsy and histopathological evaluation
At necropsy, animals were exsanguinated by section of
the aorta abdominalis and vena cava under Narcoren®
anesthesia. In accordance with the provisions of OECD
TG 412, the absolute and relative organ weights of the
adrenal glands, brain with olfactory bulb, epididymis,
heart, kidneys, liver, lungs, spleen, testes, thymus and
thyroid glands were assessed. For fixation, the lungs
were instilled (30 cm water column) with neutral buffered
10% formalin (corresponding to 4% formaldehyde). Like-
wise, the nasal cavities (4 levels) and larynxes (3 levels)
were fixed in neutral buffered 10% formalin.The organs and tissues were trimmed and sectioned
according to the trimming guides for inhalation studies
[68-70]. Paraffin sections were stained with hematoxylin
and eosin and examined by light microscopy. Full histo-
pathological examinations were performed in the ani-
mals of the control and high concentration groups. If
changes were observed in the high concentration, groups
the respective organs and tissues of the animals exposed
to the low and intermediate concentrations were also
examined.
Assessment of cell proliferation and apoptosis rates
In animals exposed to ZnO, coated nano-ZnO, nano-
CeO2, and nano-ZrO2, cell proliferation and apoptosis
rates were determined in large/medium bronchi, terminal
bronchioli, and alveoli. Three days prior to necropsy, rats
were subcutaneously implanted with Alzet osmotic pumps
(Model 2ML1, Alzet Corporation; Palo Alto, CA, USA)
containing 20 mg/ml 5-bromo-2-deoxyuridine (BrdU).
Making use of histopathological sections that were
dewaxed to remove paraffin, cell proliferation was deter-
mined after immunostaining with mouse anti-BrdU anti-
body (BioGene; Hamburg, Germany). Labeling indices
(i.e. percentage of nuclei counted undergoing replicative
DNA synthesis indicating cells present in the S-phase)
were determined for three pulmonary compartments,
namely the large/medium sized bronchi, the terminal
bronchioli and the alveoli. In each compartment, a
minimum of 1,000 cells was evaluated. Apoptosis in
lung sections was determined with a TUNEL kit (Roche
Diagnostics; Germany) employing the manufacturers’
instructions. Counts of apoptotic cells were performed in
the three pulmonary compartments mentioned above.
Organ burden analysis and TEM and EDX organ analysis
At necropsy, the lungs, the mediastinal lymph nodes,
livers, kidneys, spleens as well as the basal brains with
olfactory bulbs were excised. For organ burden analysis,
the organs and tissues were digested, and their test
material content was analysed either by Inductively
Coupled Plasma-Atomic Emission Spectrometry (ICP-
AES, Varian Vista Pro; Palo Alto, CA, USA) or by Induc-
tively Coupled Plasma-Mass Spectrometry (ICP-MS,
Agilent 7500C; Agilent Technologies; Santa Clara, CA,
USA). Sample solutions were nebulized with a Meinhard
Nebulizer (Meinhard; CO, USA), and the respective main
element of the given test substance (Ti, Zr, Si, Ba, or Ce)
was analyzed at a plasma power of 1200 W (ICP-AES)
or 1150 W (ICP-MS).
In addition to the analytically determined lung burden,
the fraction of potential pulmonary deposition (Table 4)
was calculated using the MPPD software, version 2.11
[30,31]. The MPPD model is based on the empirically
determined mass median aerodynamic diameter (MMAD)
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during nose-only inhalation studies. Since the MPPD
model requires indicating particle density, for all solid
substances, agglomerate density, determined by Hg poro-
simetry, was applied. For all liquid substances, the mate-
rial’s density was included, instead. Since these materials
only form small agglomerates, agglomerate density ap-
proaches their physical density.
For organ analysis by TEM and EDX analysis, animals
were anesthetized with isoflurane, and perfused transcar-
dially with cacodylate buffer (resulting in euthanasia by
exsanguination) and thereafter fixed with 5% glutaralde-
hyde. Lungs, mediastinal lymph nodes, brain and spleen
were embedded in epoxy resin. Semi-thin and ultra-thin
sections of the spleen were cut from 3 control animals
and 3 animals exposed to SiO2.acrylate. Sections were
assessed by TEM. For one animal, each, of the control
and dose groups, EDX analysis was performed to detect
silicon particles on the ultra-thin section.
Statistical analysis
Substance-induced effects on body weight were assessed
using Dunnett’s test [71,72] by comparing each dose
group with the corresponding control group. All BALF
data and the serum mediator data were subjected to
non-parametric one-way analysis using the Kruskal-
Wallis test (two-sided). If the resulting p value was 0.05
or below, a pairwise comparison of each dose group with
the corresponding control group was performed using
the two-sided Wilcoxon test or the two-sided Mann–
Whitney U-test [73]. Cell proliferation and apoptosis
data were analysed by pairwise comparison of each dose
group with the corresponding control group using the
one-sided Wilcoxon test.
Additional files
Additional file 1: Tables S1-S9. Substance-induced effects in the
bronchoalveolar fluid (BALF) or lung tissue homogenates.
Additional file 2: Tables S10-S15. Summary of incidences and severities
of histopathological observations in rats exposed to TiO2, ZnO and CeO2
test materials.
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